Healthcare, the world's largest industry, is transforming faster than ever. The focus on outcomes based medicine and optimal health management of populations will result in major seismic shifts. Modernization and reform measures are being employed globally by public and private sector organizations to meet the growing need for healthcare. New technologies are being created, offering enormous promise to improve care delivery.

Our Transformational Health practice serves all key industry stakeholders through partnership models that provide access to high-quality content and our global team of industry experts. The practice includes Visionary Health, Life Sciences, Advanced Medical Technologies and Connected Health, focusing on evolving healthcare technologies and covering the entire industry spectrum

  1. 20 Jul 2022  |  Europe

    Global Mammography Vendor Profiles and Growth Opportunities

    Transformational Growth Driven by Disruptive AI Solutions Enhancing Workflow Efficiency and Clinical Decision-Making

    This Frost & Sullivan study examines the role of artificial intelligence (AI) in the global mammography market. The high prevalence of breast cancer in women has increased the demand for breast cancer screening, which, in turn, heightened the focus on using AI-based solutions for mammography. AI solutions can reduce results variability among radiol...

  2. 14 Jul 2022  |  North America

    Women’s Health Solution Growth Opportunities

    Disruptive Technologies and Competitive Intensity are Driving Innovations in the Medtech Industry

    As the healthcare industry moves toward the ideas of personalized medicine and health equity, an important consideration in disease and treatment experiences is gender. While fine-tuning treatment paradigms for women will probably take decades, several areas of women’s health are possible to address even today. This project focuses on 3 speci...

  3. 14 Jul 2022  |  North America

    United States Molecular Point-of-Care Testing Growth Opportunities

    Syndromic Point-of-Care Testing Drives Transformational Growth in Infectious Disease Diagnostics

    Rapid advancements in infectious disease diagnostics continue with novel identification methods and healthcare accessibility improvements. The shift from traditional testing to a more technologically empowered, consumer-centric testing encompasses the sample-in-answer-out approach of diagnostic testing that generates results in minutes or hours. Nu...

  4. 06 Jul 2022  |  Global

    Global Ultrasound Growth Opportunities

    Owing to the COVID-19 Pandemic, the Use of Tele-ultrasound has Increased Rapidly and Helped to Close the Gap between Providing Quality Care and Accessibility to a Larger Patient Base

    New solutions include the integration of tools such as AI, which streamlines processes by automating tasks and offering guidance to operators on the use of ultrasound equipment. These solutions also reduce variabilities across devices and operators and improve the early diagnosis of chronic diseases. The study will help ultrasound equipment prov...

  5. 05 Jul 2022  |  North America

    In Vitro Diagnostic eCommerce Business Models Growth Opportunities

    Disruptive Differentiation in Supply Chain Management Drives New Growth Potential

    Diagnostics are central to healthcare, but not accessible to all. A 2020 Lancet study states that 47% of the global population has little to no access to accurate diagnostics, emphasizing the need for equitable distribution across geographies and containing procurement costs. The COVID-19 pandemic increased demand for personal protective equipment,...

  6. 04 Jul 2022  |  Global

    Global Neonatal Care Devices Growth Opportunities

    Growth Potential is Enhanced by Family-centric and Holistic Developmental Care Neonatal Devices

    The neonatal care industry is shifting its focus to providing family-centric and developmental care to neonates. Neonatal Intensive Care Units (NICUs) are looking at reducing neonatal stress, such as noise and intense light, to provide complete holistic care for neonates. Wireless capabilities and portability are the new features in neonatal care d...

  7. 04 Jul 2022  |  North America

    Global Cardiac Monitoring Devices Growth Opportunities

    Wearables will Drive the Future Growth Potential of Cardiac Monitoring

    This research service provides an overview of the global cardiac monitoring devices market. The geographical scope of this global study is North America (NA), Europe, and Asia-Pacific (APAC). It offers a detailed analysis of market sizing, trends, competitive landscape, future market outlook by region, and growth opportunities. The market is segmen...

  8. 22 Jun 2022  |  Global

    Global Operating Room Devices and Solutions Growth Opportunities

    Emerging Business Models & Strategies for Cash-strapped Hospitals

    Hospitals are under extreme pressure to reduce costs and increase profits. Considering today’s uncertain regulatory climate and challenging economic environment, medical device companies are challenged to provide products and services to hospitals at an affordable cost. The operating room (OR) offers many opportunities to do so. ORs drive approxi...

  9. 16 Jun 2022  |  North America

    US Health Equity Growth Opportunities

    Digital Health Solutions are Boosting the Future Growth Potential of Health Equity

    Health equity is achieved when all sections of the population have attained their full potential for health and well-being, regardless of cultural background or socioeconomic status. Inequities resulting from differences in health and overall living conditions need to be identified and removed to realize health equity. Monitoring health inequity pa...

  10. 08 Jun 2022  |  North America

    Growth Opportunities in Sterile Injectable Outsourcing

    Biologics Drive the Future Growth Potential of Sterile Injectable Outsourcing

    Injectables constitute one of the fastest growing segments in the pharmaceuticals space. Many drugs, including biologics, are going off patent in next 3 or 4 years, which will lead to an increase in the demand for generics and biosimilar injectables. The increase in onshoring and nearshoring of biopharmaceutical products for COVID-19 and next-gen...